Pre-earnings options volume in Zevra Therapeutics (ZVRA) Inc is 1.2x normal with calls leading puts 8:1. Implied volatility suggests the market is anticipating a move near 4.6%, or 41c, after results are released. Median move over the past eight quarters is 3.3%.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ZVRA:
- Options Volatility and Implied Earnings Moves Today, March 09, 2026
- Is ZVRA a Buy, Before Earnings?
- Zevra Therapeutics appoints Renz as Chief Financial Officer
- Reaffirming Buy on Zevra: Durable Miplyffa Efficacy and Annuity-Like NPC Revenue Support $26 Target
- Zevra Therapeutics presents real-world data on Miplyffa